Susan Michaelis, Ph.D.

Headshot of Susan Michaelis
  • Professor of Cell Biology

Research Interests

ER quality control; Mammalian cell biology; Cytosolic protein quality control; ABC transporters; ERAD; ZMPSTE24 protease; Lamin A; Endocytosis; Hutchinson-Gilford progeria syndrome (HGPS or progeria); Yeast protein trafficking and human disease more


Dr. Susan D. Michaelis is a professor of cell biology in the Johns Hopkins University School of Medicine.

A researcher, Dr. Michaelis uses yeast and mammalian cell biology, biochemistry and high-throughput genomic approaches to dissect fundamental cellular processes relevant to human health and disease.

She is involved with the Human Genetics, Cellular and Molecular Medicine, and Biochemistry, Cellular and Molecular Biology Graduate Programs at Johns Hopkins University School of Medicine. more


  • Professor of Cell Biology
  • Professor of Genetic Medicine

Departments / Divisions

Centers & Institutes

Research & Publications

Research Summary

The overarching goal of Dr. Michaelis’s research is to dissect fundamental cellular processes relevant to human health and disease, using yeast and mammalian cell biology, biochemistry, and high-throughput genomic approaches.

One of her team’s focuses is the premature aging disease Hutchinson-Gilford progeria syndrome (HGPS), which results from a mutation in the gene encoding the nuclear scaffold protein lamin A. Children with HGPS exhibit profound characteristics of aging, including hair loss, skin and bone defects, and heart disease.

The mutant form of lamin A in HGPS patient cells is persistently modified by the lipid farnesyl, an aberrant situation, since normally cleavage by the ZMPSTE24 protease removes the farnesylated C-terminal tail of lamin A during biogenesis.

Dr. Michaelis and her group are examining the cell biology of lamin A processing, the molecular mechanisms of lamin A toxicity in HGPS, mechanistic features of the ZMPSTE24 membrane protease, therapeutic strategies, and the link between HGPS and normal aging.

The team also studies protein quality control mediated by the ubiquitin-proteasome system. Misfolded secretory and membrane proteins are efficiently degraded by ER-associated degradation (ERAD), while cytosolic quality control (CytoQC) pathways handle misfolded soluble proteins.

Their research goal is to identify the core cellular machinery involved in recognition of misfolded proteins, using model proteins as “bait” in genome-wide yeast screens designed to uncover the eukaryotic ERAD and CytoQC machinery.

Ultimately devising treatment for protein misfolding diseases in which degradation is too efficient (e.g. cystic fibrosis) or not efficient enough (e.g., neurological disorders like Parkinson’s) will rely on a detailed understanding of cellular protein quality control machinery.

Selected Publications

Michaelis S and Hrycyna CA. (2013) “A protease for the ages.” Science 339:1529-30

Kane MS, Lindsay ME, Judge DP, Barrowman J, Ap Rys C, Simonson L, Dietz HC, Michaelis S. (2013) “LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset.” American Journal of Medical Genetics, Part A (In Press).

Michaelis S, and Barrowman J. “Biogenesis of the Saccharomyces cerevisiae pheromome a-factor; from yeast mating to human disease.” (2012) Microbiology and Molecular Biology Reviews 76: 626-651.

Barrowman J, Wiley PA, Hudon S, Hrycyna CA, Michaelis, S. (2012) “Human ZMPSTE24 disease mutations: residual enzymatic activity correlates with disease severity.” Human Molecular Genetics 21:4084-4093.

Barrowman J, Hamblet C, Kane MS, Michaelis S. (2012) “Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.” PLoS ONE 7: e32120.

Academic Affiliations & Courses

Graduate Program Affiliation

Biochemistry, Cellular and Molecular Biology

Cellular and Molecular Medicine

Human Genetics

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button